Cargando…
DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A binding
BACKGROUND: Genome-wide association studies (GWASs) have identified dozens of loci associated with gout, but for most cases, the risk genes and the underlying molecular mechanisms contributing to these associations are unknown. This study sought to understand the molecular mechanism of a common gene...
Autores principales: | Zhu, Zaihua, Meng, Weida, Liu, Peiru, Zhu, Xiaoxia, Liu, Yun, Zou, Hejian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603049/ https://www.ncbi.nlm.nih.gov/pubmed/28932319 http://dx.doi.org/10.1186/s13148-017-0401-z |
Ejemplares similares
-
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes
por: Orso, Francesca, et al.
Publicado: (2010) -
Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia
por: Cao, Ling, et al.
Publicado: (2021) -
NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt/β-catenin signaling pathway
por: Wei, Hong, et al.
Publicado: (2015) -
Hypomethylation of ETS Transcription Factor Binding Sites and Upregulation of PARP1 Expression in Endometrial Cancer
por: Bi, Fang-Fang, et al.
Publicado: (2013) -
CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1
por: Qin, Linghui, et al.
Publicado: (2021)